Role of Cysteine and Glutathione in HIV Infection and Cancer Cachexia: Therapeutic Intervention with N-Acetylcysteine

Advances in Pharmacology

Volumn 38, Issue C, 1996, Pages 581-600

  DrÖGe, Wulf ^a   Gross, Andrea ^a   Hack, Volker ^a   Kinscherf, Ralf ^a   Schykowski, Michael ^a   Bockstette, Michael ^a   Mihm, Sabine ^a   Galter, Dagmar ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0006577137     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)61000-5     Document Type: Article

References (88)

1. Akerboom T.P.M., and Sies H. Transport of glutathione disulfide and glutathione S-conjugates in hepatocyte plasma membrane vesicles. Methods Enzymol. 233 (1994) 416-425
2. Akerboom T.P.M., and Sies H. Interorgan transport of glutathione and glutathione S-conjugates. In: Eyer P. (Ed). "Metabolic Aspects of Cell Toxicity" (1994), BI Wissenschaftsverlag, Mannheim 7-30
3. Aoki T., Miyakoshi H., Usuda Y., and Herberman R.B. Low NK syndrome and its relationship to chronic fatigue syndrome. Clin. Immunol. Immunopathol. 69 (1993) 253-265
4. Askanazi J., Carpentier Y.A., Michelsen C.B., Elwyn D.H., Furst P., Kantrowitz L.R., Gump F.E., and Kinney J.M. Muscle and plasma amino acids following injury. Ann. Surg. 192 (1980) 78-85
5. + lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection. Blood 86 (1995) 258-267
6. Aulick L.H., and Wilmore D.W. Increased peripheral amino acid release following burn injury. Surgery 85 (1979) 560-566
7. Baeuerle P.A., and Baltimore D. In: Cohen P., and Foulkes J.G. (Eds). "Molecular Aspects of Cellular Regulation, Hormonal Control Regulation of Gene Transcription" (1991), Elsevier/North-Holland Biomedical Press, Amsterdam 423-446
8. + cytotoxic T lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68 (1994) 6103-6109
9. Bouvier M., Szatkowski M., Amato A., and Attwell D. The glial cell glutamate uptake carrier countertransports pH-changing anions. Nature 360 (1992) 471-474
10. Braun D.P., Cobleigh M.A., and Harris J.E. Multiple concurrent immunoregulatory effects in cancer patients with depressed PHA induced lymphocyte DNA synthesis. Clin. Immunol. Immunopathol. 17 (1980) 89-101
11. Brennan M.F. Uncomplicated starvation versus cancer cachexia. Cancer Res. 37 (1977) 2359-2364
12. Buchbinder S.P., Katz M.H., Hessol N.A., O'Malley P.M., and Holmberg S.D. Long-term HIV-1 infection without immunologic progression. AIDS 8 (1994) 1123-1129
13. Buhl R., Holroyd K., Mastrangeli A., Cantin A.M., Jaffe H.A., Wells F.B., Saltini C., and Crystal R.G. Systemic glutathione deficiency in symptom-free HIV-soropositive individuals. Lancet Dec. 2 (1989) 1294-1298
14. Cerra F.B., Siegel J.H., and Coleman B. Septic autocannibalism: A failure of exogenous nutritional support. Ann. Surg. 192 (1980) 570-574
15. Collins P.B., Johnson A.H., and Moriarty M. T lymphocytes in human cancer. I. Mitogen-responsiveness of lymphocytes in cancer patients. Ir. J. Med. Sci. 149 (1980) 301-303
16. Dröge W., Eck H.-P., Betzler M., Schlag P., Drings P., and Ebert W. Plasma glutamate concentration and lymphocyte activity. J. Cancer Res. Clin. Oncol. 114 (1988) 124-128
17. Dröge W., Eck H.-P., and Mihm S. HIV-induced cysteine deficiency and T cell dysfunction: A rationale for treatment with N-acetylcysteine. Immunol. Today 13 (1992) 211-214
18. Dröge W., Eck H.-P., Näher H., Pekar U., and Daniel V. Abnormal amino acid concentrations in the blood of patients with acquired immunodeficiency syndrome (AIDS) may contribute to the immunological defect. Biol. Chem. Hoppe-Seyler 369 (1988) 143-148
19. Dröge W., Kinscherf R., Mihm S., Galter D., Roth S., Gmünder H., Fischbach T., and Bockstette M. Thiols and the immune system. Effect of N-acetylcysteine on T cell system in human subjects. Methods Enzymol. 251 (1995) 255-270
20. Dröge W., Pottmeyer-Gerber C., Schmidt H., and Nick S. Glutathione augments the activation of cytotoxic T lymphocytes in vivo. Immunobiology 172 (1986) 151-156
21. Dröge W., Schulze-Osthoff K., Mihm S., Galter D., Schenk H., Eck H.-P., Roth S., and Gmunder H. Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J. 8 (1994) 1131-1138
22. Duff J.H., Viidik T., Marchuk J.B., et al. Femoral arteriovenous amino acid differences in septic patients. Surgery 85 (1979) 344-348
23. Eck H.-P., and Dröge W. Influence of the extracellular glutamate concentration on the intracellular cyst(e)ine concentration in macrophages and on the capacity to release cysteine. Biol. Chem. Hoppe-Seyler 370 (1989) 109-113
24. Eck H.-P., Gmünder H., Hartmann M., Petzoldt D., Daniel V., and Dröge W. Low concentrations of acid soluble thiol (cysteine) in the blood plasma of HIV-1 infected patients. Biol Chem Hoppe-Seyler 370 (1989) 101-108
25. Eck H.-P., Stahl-Hennig C., Hunsmann G., and Dröge W. Metabolic disorder as an early consequence of simian immunodeficiency virus infection in rhesus macaques. Lancet 338 (1991) 346-347
26. Fontana L., Sirianni M.C., De Sanctis G., Carbonari M., Ensoli B., and Aiuti F. Deficiency of natural killer activity, but not of natural killer binding, in patients with lymphoadenopathy syndrome positive for antibodies to HTLV-III. Immunobiology 171 (1986) 425-435
27. Friedman P.J. Is wasting itself lethal? A case-control prospective study. Nutr. Res. 7 (1987) 707-717
28. Furst P., Bergström J., Chao L., Larsson J., Liljedahl S.-O., Neuhauser M., Schildt B., and Vinnars E. Influence of amino acid supply on nitrogen and amino acid metabolism in severe trauma. Acta Chir. Scand. Suppl. 494 (1979) 136-141
29. Galter D., Mihm S., and Dröge W. Dinstinct effects of glutathione disulphide on the nuclear transcription factors KB and the activator protein-1. Eur. J. Biochem. 221 (1994) 639-648
30. Giorgi J.V., and Detels R. T cell subset alterations in HIV-infected homosexual men: NIAID multicenter AIDS cohort study. Clin. Immunol. Immunopathol. 52 (1989) 10
31. Gmünder H., Eck H.-P., and Dröge W. Low membrane transport activity for cystine in resting and mitogenically stimulated human lymphocyte preparations and human T cell clones. Eur. J. Biochem. 201 (1991) 113-117
32. Grunfeld C. Mechanisms of wasting in infection and cancer: An approach to cachexia in AIDS. In: Kotler D.P. (Ed). "Gastrointestinal and Nutritional Manisfestions of AIDS" (1991), Raven Press, New York 207-229
33. Hack V., Gross A., Kinscherf R., Bockstette M., Fiers W., Berke G., and Dröge W. Abnormal glutathione and sulfate levels after interleukin-6 treatment and in tumor-induced cachexia. FASEB J. 10 (1996) in press.
34. Hack V., Stütz O., Kinscherf R., Schykowski M., Kellerer M., Holm E., and Dröge W. Elevated venous glutamate levels in (pre)catabolic conditions result at least partly from a decreased glutamate transport activity. J. Mol. Med. 74 (1996) 337-343
35. Harnett W.L. A survey of cancer in London. Bri. Empire Cancer Campaign (1952) 26
36. -3, pH and the activity of carbonic anhydrase. Eur. J. Biochem. 152 (1985) 381-386
37. Herberman R.B., and Ortaldo J.R. Natural killer cells: Their role in defenses against disease. Science 214 (1981) 24-30
38. Horn L.W. L-Glutamate transport in internally dialysed barnacle muscle fibres. Am. J. Physiol. 257 (1989) C442-C450
39. Hortin G.L., Landt M., and Powderly W.G. Changes in plasma amino acid concentrations in response to HIV-1 infection. Clin. Chem. 40 (1994) 785-789
40. Ishii T., Sugita Y., and Bannai S. Regulation of glutathione levels in mouse spleen lymphocytes by transport of cysteine. J. Cell Physiol. 133 (1987) 330-336
41. Kanner B.I. Glutamate transporters from brain: A novel neurotransmitter transporter family. FEBS Lett. 325 (1993) 95-99
42. + cells. FASEB J. 8 (1994) 448-451
43. Kinscherf R., Hack V., Fischbach T., Friedmann B., Weiss C., Edler L., Bärtsch P., and Dröge W. Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass (BCM) in healthy individuals: The effect of N-acetyl-cysteine on BCM. J. Mol. Med. (1996) in press.
44. Klein Mr., and Van Baalen C.A. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HN-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181 (1995) 1356-1365
45. Kotler D.P., Wang J., and Pierson R. Body composition in patients with the acquired immunodeficiency syndrome. Am. J. Clin. Nutr. 42 (1985) 1255-1265
46. Lawson D.H., Richmond A., Nixon D.W., et al. Metabolic approaches to cancer cachexia. Annu. Rev. Nutr. 2 (1982) 277-301
47. Lim J.-S., Eck H.-P., Gmünder H., and Dröge W. Expression of increased immuno-genicity by thiol releasing tumor variants. Cell. Immunol. 140 (1992) 345-356
48. Long C.L., Crosby F., Geiger J.W., and Kinney J.M. Parenteral nutrition in the septic patient: Nitrogen balance, limiting plasma amino acids, and calorie to nitrogen ratios. Am. J. Clin. Nutr. 29 (1976) 380-391
49. Low S.Y., Rennie M.J., and Taylor P.M. Sodium-dependent glutamate transport in cultured rat myotubes increases after glutamate deprivation. FASEB J. 8 (1994) 127-131
50. Matthews J.R., Wakasugi N., Virelizier J.-L., Yodoi J., and Hay R.T. Thioredoxin regulates the DNA binding activity of NF-KB by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res. 20 (1992) 3821-3830
51. Mcgivan J.D., and Pastor-Anglada M. Regulatory and molecular aspects of mammalian amino acid transport. Biochem. J. 299 (1994) 321-334
52. Meister A., and Anderson M.E. Glutathione. Annu. Rev. Biochem. 52 (1983) 711-760
53. Miedema F., Petit A.J.C., Terpstra F.G., Schattenkerk J.K.M.E., De Wolf F., Al B.J.M., Roos M., Lange J.M.A., Danner S.A., Gandsmit J., and Schellekens P.T.A. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. J. Clin. Invest. 82 (1988) 1908
54. Miescher S., Whiteside T.L., Carrel S., and Von Fliedner V. Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: Effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J. Immunol. 136 (1986) 1899-1907
55. Mihm S., Galter D., and DrÖGe W. Modulation of transcription factor NFKB activity by intracellular glutathione levels and by variations of the extracellular cysteine supply. FASEB J. 9 (1995) 246-252
56. Müller D.S., Manger B., Zawatzky R., Kirchner H., and Kalden J.R. Mitogen-induced pigg-interferon production in peripheral blood lymphocytes from patients with coforectal tumors. Immunobiology 166 (1984) 494-499
57. Newsholme E.A., and Parry-Billings M. Properties of glutamine release from muscle and its importance for the immune system. J. Parent. Ent. Nutr. 14 (1990) 63S-67S
58. Okamoto T., Ogiwara H., Hayashi T., Mitsui A., Kawabe T., and Yodoi J. Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism. Int. Immunol. 4 (1992) 811-819
59. Pantaleo G., Graziosi C., and Fauci A.S. The immunopathogenesis of human immunodeficiency virus infection. N. Engl. J. Med. 328 (1993) 327-335
60. Pisters P.W., and Pearlstone D.B. Protein and amino acid metabolism in cancer cachexia: Investigative techniques and therapeutic interventions. Crit. Rev. Clin. Lab. Sci. 30 (1993) 223-272
61. Plaitakis A., and Caroscio J.T. Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 22 (1987) 575-579
62. Poli G., Introna M., Zanaboni F., Peri G., Carbonari M., Aiuti F., Lazzarin A., Moroni M., and Mantovani A. Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome. Clin. Exp. Immunol. 62 (1985) 128-135
63. Rinaldo C., Huang X.-L., Fan Z., Ding M., Beltz L., Panicali D., Mazzara G., Liebmann J., Cattrill M., and Gupta P. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69 (1995) 5838-5844
64. Roederer M., Staal F.J.T., Osada H., Herzenberg L.A., and Herzenberg L.A. CD4 and CD8 T cells with high intracellular glutathione levels are selectively lost as the HIV infection progresses. Int. Immunol. 3 (1991) 933-937
65. Rosenberg Z.F., and Fauci A.S. The immunopathogenesis of HIV infection. Adv. Immunol. 47 (1989) 377-431
66. Roth E. Untersuchungen zum Aminosäuren- und Proteinstofhechsel bei kritisch Kranken. Infusionstberapie 12 (1985) 270-280
67. Roth E., Funovics J., Mtihlbacher F., Schemper M., Mauritz W., Sporn P., and Fritsch A. Metabolic disorders in severe abdominal sepsis: Glutamine deficiency in skeletal muscle. Clin. Nutr. 1 (1982) 25-41
68. Roth E., Mühlbacher F., Karner J., Steininger R., Schemper M., and Funovics J. Liver amino acids in sepsis. Surgery 97 (1985) 436-442
69. Schenk H., Klein M., Dröge W., and Schulze-Osthoff K. Dinstinct effects of thioredoxin and antioxidants on the activation of NFKB and AP-1. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 1672-1676
70. Shaw J.H.F., and Wolfe R.R. Glucose and urea kinetics in patients with early and advanced gastrointestinal cancer: The response to glucose infusion and TPN. Surgery 101 (1987) 181-186
71. Shaw J.H., Humberstone D.A., and Holdaway C. Weight loss in patients with head and neck cancer: Malnutrition or tumor effect?. Aust. N. Z. J. Surg. 58 (1988) 505-509
72. Shaw, Klien J.H.F., and Wolfe R.R. Assessment of alanine, urea and glucose interrelationships in normal subjects and in patients with sepsis using stable isotopic tracers. Surgery 97 (1985) 557-567
73. Siegel J.H., Cerra F.B., Coleman B., et al. Physiological and metabolic correlations in human sepsis. Surgery 86 (1979) 163-192
74. Sirianni M.C., Tagliaferri F., and Aiuti F. Pathogenesis of the natural killer cell deficiency in AIDS. Immunol. Today 11 (1990) 81-82
75. Souba W.W., and Wilmore D.W. Postoperative alteration of arteriovenous exchange of amino acids across the gastrointestinal tract. Surgery 94 (1983) 342-350
76. Süttmann U., Hoogestraat L., Ockenga J., Coldewey R., Schedel I., Deicher H., and Müller M.J. Ernährungszustand und Immundefekt bei Patienten mit HIV-1-Infektion. Infusionstberapie 18 (1991) 72-73
77. Süttmann U., Ockenga J., Selberg O., Hoogestraat L., Deicher H., and Muller M.J. Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J. Acq. Immune Defic. Syndr. Hum. Retrovirol. 8 (1995) 239-246
78. Tayek J.A. A review of cancer cachexia and abnormal glucose metabolism in humans with cancer. J. Am. Col. Nutr. 11 (1992) 445-456
79. Tötterman T.H., Parthenais E., Häyry P., Timonen T., and Saksela E. Cytological and functional analysis of inflammatory infiltrates in human malignant tumors. Cell. Immunol. 55 (1980) 219-226
80. Ullmann K.S., Northrop J.P., Verweij C.L., and Crabtree G.R. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Annu. Rev. Immunol. 8 (1990) 421-452
81. Ullum H., Gotzsche P.C., Victor J., Dickmeiss E., Skinhoj P., and Pedersen B.K. Defective natural immunity: An early manifestation of human immunodeficiency virus infection. J. Exp. Med. 182 (1995) 789-799
82. Vose B.M., Vanky F., and Klein E. Human tumor-lymphocyte interaction in vitro. V. Comparison of the reactivity of tumor-infiltrating blood and lymph-node lymphocytes with autologous tumor cells. Int. J. Cancer 20 (1977) 895-902
83. Wanebo H.J., Jun M.Y., Strong E.W., and Oettgen H. T cell deficiency in patients with squamous cell cancer of the head and neck. Am. J. Surg. 130 (1975) 445-448
84. Warren S. The immediate causes of death in cancer. Am. J. Med. Sci. 184 (1932) 610-615
85. Watkins S.M. The effects of surgery in lymphocyte transformation in patients with cancer. Clin. Exp. Immunol. 14 (1973) 69-76
86. Wilmore D.W., Goodwin C.W., Aulick L.H., et al. Effect of injury and infection on visceral metabolism and circulation. Ann. Surg. 192 (1980) 491-504
87. Yron I., Schickler M., Fisch B., Pinkas H., Ovadia J., and Witz I.P. The immune system during the pre-cancer and the early cancer period: IL-2 production by PBL from postmenopausal women with and without endometrial carcinoma. Int. I. Cancer 38 (1986) 331-338
88. Zhang P.C., and Pang C.P. Plasma amino acid patterns in cancer. Clin. Chem. 38 (1992) 1198-1199